CLINICAL_TRIALS
trial_result
· 2026-01-15
Clinical Trial Update: Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD [Phase 2, Phase 3]
Summary
A pediatric ADHD study of NRCT-101SR in Phase 2/3 has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocentria, Inc. | Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD) | Phase 2, Phase 3 | Status: TERMINATED